In 1999, the first tyrosine kinase inhibitor (TKI) transformed the treatment of chronic myeloid leukemia - and changed the course of cancer care worldwide.

This year, we mark 25 years since that breakthrough. It’s more than a scientific milestone - it’s a story of lives extended and a global community working to ensure access to treatment for all.

To honor this anniversary, the iCMLf is sharing reflections, resources, and real-world impact from across our network:

🔹 Read the Campaign Announcement →

Learn how the iCMLf is recognising this global milestone and how you can get involved.

🔹 Explore the Timeline →

Walk through the milestones of 25 years of progress in the development of TKIs.

🔹 Read the Dr. Brian Druker Interview →

Hear directly from the man who helped pioneer TKIs, reflecting on what’s changed - and what comes next.